BC Cancer - Surrey

13750 96th Avenue
Surrey, BC, V3V 1Z2

Clinical Trial Unit Manager
Nicole Valade
604-319-8067
nicole.valade@bccancer.bc.ca

Head and neck

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients with High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Back to top